Renal tubular transport disease
MONDO:0006510Genetic defects in the selective or non-selective transport functions of the kidney tubules.
Also known as: disorder of renal absorption, renal absorption disease, kidney tubular transport, inborn error, kidney tubular transport, inborn errors, renal tubular transport errors, renal tubular transport, inborn error
17 clinical trials for this condition and its sub-types, 0 tagged with Renal tubular transport disease itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Renal tubular transport disease
-
Dent disease 5 trials
2 sub-types
- Dent disease type 1 0 trials
- Dent disease type 2 0 trials
-
Pseudohypoaldosteronism 3 trials · 5 incl. sub-types
2 sub-types
- Inherited pseudohypoaldosteronism 0 trials · 4 incl. sub-types Sub-types →
- Transient pseudohypoaldosteronism 0 trials
-
Fanconi renotubular syndrome 4 trials
4 sub-types
- Deal Barratt Dillon syndrome 0 trials
- Acquired Fanconi syndrome 0 trials Sub-types →
- Adult Fanconi syndrome 0 trials
- Inherited Fanconi renotubular syndrome 0 trials Sub-types →
-
Renal tubular acidosis 2 trials
5 sub-types
-
Liddle syndrome 1 trial
3 sub-types
- Liddle syndrome 1 0 trials
- Liddle syndrome 2 0 trials
- Liddle syndrome 3 0 trials
-
Renal hypomagnesemia 3 1 trial
-
Bartter syndrome 0 trials
6 sub-types
- Bartter disease type 1 0 trials
- Bartter disease type 2 0 trials
- Bartter disease type 3 0 trials
- Bartter disease type 5 0 trials
- Bartter syndrome type 4 0 trials Sub-types →
- Bartter syndrome with hypocalcemia 0 trials
-
Gitelman syndrome 0 trials
-
Familial renal glucosuria 0 trials
Most studied deeper sub-types
-
Potassium binder lets heart patients get full drug benefits
Disease control CompletedThis study tested whether a drug called Lokelma (SZC) can help people with both chronic kidney disease and heart failure safely reach higher doses of life-saving heart medications (RAAS inhibitors) without dangerous potassium spikes. 112 adults with stable kidney disease and hear…
Phase 3 • Sponsor: St George's, University of London • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
NIH study aims to unlock secrets of lung mucus diseases
Knowledge-focused CompletedThis completed study looked at people with genetic conditions that affect how the lungs clear mucus, such as cystic fibrosis and primary ciliary dyskinesia. Researchers examined 87 participants, including healthy volunteers, to understand why these patients get repeated lung infe…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:08 UTC
-
New antibiotic combo tested for safety in healthy volunteers
Knowledge-focused CompletedThis early-stage study tested the safety and how the body processes two antibiotics—Zidebactam-Cefepime and Metronidazole—given alone or together. Thirty healthy adults received single doses in three different sequences. The goal was to measure drug levels and check for side effe…
Phase 1 • Sponsor: Wockhardt • Aim: Knowledge-focused
Last updated Jun 26, 2026 17:37 UTC